Pipeline

Progress is our most important product

PRODUCT

TARGET

INDICATION

DISCOVERY

PRECLINICAL

CLINICAL POC

PIVOTAL

WU CART 007

CD7

T-ALL/T-NHL/AML

WU CART 002

CD2

T-ALL/T-NHL

WU ALLO CART

CONFIDENTIAL

AML

WU IMMPOT

CONFIDENTIAL

Multiple Indications

WU CD CAR

CONFIDENTIAL

MM

Progress is our most important product

IMMPOT = Immunopotentiation
CD CAR = Conditional CAR

T-ALL = T-cell Acute Lymphoblastic Leukemia
T-NHL = T-cell Non-Hodgkin’s Lymphoma
AML = Acute Myeloid Leukemia
MM = Multiple Myeloma

Scroll to Top